Risperdal Lawsuit Ends in Win for Plaintiff, But No Damages

Jury Finds Risperdal Caused Plaintiff’s Gynecomastia, But Awards No Financial Damages On Friday, March 20th, the jury for the latest Risperdal personal injury lawsuit ruled that Johnson & Johnson failed to warn doctors and patients of the risks of using Risperdal for off-label prescriptions, which led to the plaintiff’s gynecomastia; however, … [Read more...]

J&J Wins Cut in South Carolina Risperdal Judgment

J&J Successfully Gets South Carolina Risperdal Judgement - Damages Cut in Half Although Johnson & Johnson, and its subsidiary Janssen Pharmaceuticals, face thousands of Risperdal personal injury lawsuits combined in a multidistrict litigation (MDL) in Philadelphia, the companies are fighting previous penalties for off-label use in numerous … [Read more...]

Former FDA Chief Testified J&J Knew Risperdal Dangers

Ex-FDA Chief Testified in Risperdal Trial that J&J Knew About Dangerous Side Effects According to testimony in the current Risperdal trial, Johnson & Johnson knew as early as 2001 that it’s antipsychotic drug had serious, dangerous side effects, including that it could cause gynecomastia (female breast tissue growth) in young boys. Former … [Read more...]

Montana Settles Risperdal Lawsuit for $5.9 Million

Janssen To Pay $5.9 Million Settlement to Montana for Misleading Ads In March of this year, Montana State Attorney General Tim Fox announced that Johnson & Johnson’s subsidiary Janssen Pharmaceuticals agreed to pay $5.9 million to settle allegations in the state regarding its antipsychotic drug, Risperdal. Like many Risperdal settlements in … [Read more...]

BestLawyers.comAVBetter Business Bureau